Degrader-Antibody Conjugates: The Next Generation of ADCs
- Overviewing principles of targeted protein degraders to improve specificity of tumor-cell killing
- Explore the advantages of TPDs as therapeutic payloads
- Assessing the applications for degrader-antibody conjugates in oncology and immunology as the future of precise targeting